Description: FSD Pharma Inc., through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is headquartered in Cobourg, Canada.
Home Page: www.fsdpharma.com
HUGE Technical Analysis
199 Bay Street
Toronto,
ON
M5L 1A9
Canada
Phone:
416 854 8884
Officers
| Name | Title |
|---|---|
| Mr. Zeeshan Saeed | Founder, Pres & Exec. Co-Chairman |
| Mr. Anthony John Durkacz | Founder, Interim CEO & Exec. Co-Chairman |
| Mr. Nathan Coyle CPA | Chief Financial Officer |
| Mr. Donal Carroll CPA | COO & Director |
| Ms. Maryann Adesso | Corp. Sec. |
| Randell Mack | Pres of FSD BioSciences |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Information Technology |
|---|---|
| GIC Group: | Software & Services |
| GIC Industry: | IT Services |
| GIC Sub-Industry: | Internet Services & Infrastructure |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.875 |
| Price-to-Sales TTM: | 91.8563 |
| IPO Date: | 2018-06-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 10 |